#USA #Milwaukee #Medical Research #Jorge Di Paola #Vesiti Blood Research Institute

Major Leadership Shift at Versiti Blood Research Institute

In a significant move for the field of hematology, Versiti has announced the appointment of Dr. Jorge Di Paola, an esteemed physician-scientist, as Executive Vice President and Chief Scientific Officer. This transition will become effective on October 1, 2026, and marks a pivotal moment for the globally recognized Versiti Blood Research Institute (VBRI). Dr. Di Paola will not only lead the institute but also serve as Associate Dean of Research and Professor of Pediatrics at the Medical College of Wisconsin.

Dr. Di Paola comes to Versiti with an extensive background in pediatric hematology and oncology. Currently a professor at Washington University School of Medicine, he holds the Elizabeth Finney McDonnell Endowed Chair in Pediatric Hematology Oncology. His contributions have significantly enhanced our understanding of critical areas such as inherited bleeding disorders, platelet biology, and various blood diseases, with over 200 published scientific papers to his name.

Having collaborated with Versiti researchers for over 20 years, Dr. Di Paola has built a reputation for being a leading figure in blood research and has served as an adjunct investigator at the VBRI since 2018. His past work with the NIH-funded Zimmerman Program has further solidified his expertise in addressing blood disorders and advancing the field.

According to Chris Miskel, President and CEO of Versiti, “Jorge is a deeply respected scientist, physician, and leader whose work has helped shape the field of hematology and blood research. What makes this especially meaningful for Versiti is that Jorge already knows our mission, our people, and the scientific culture that defines the VBRI.” Miskel describes Dr. Di Paola’s appointment as crucial for guiding the next phase of research and innovation at Versiti, with a shared understanding of how discovery and clinical care can coalesce to enhance patient well-being.

Dr. Di Paola's leadership extends beyond his scientific contributions. He has served as deputy editor of the journal Blood, a preeminent publication in the field, and held the presidential role at the American Society of Pediatric Hematology/Oncology. His commitments reflect a professional dedication to mentorship and fostering new talent in the field.

The impact Dr. Di Paola has had at Washington University is undeniable. He played a crucial role in growing research initiatives and faculty staffing within the pediatric hematology-oncology division, showing his capability in both scientific and leadership dimensions. His engaging mentorship programs for future physician-scientists highlight his investment in the next generation.

Expressing his commitment to the role, Dr. Di Paola stated, “Versiti has been an important part of my scientific career for many years. This is a remarkable moment for blood research and translational medicine, and I believe Versiti is uniquely positioned to help shape the future of the field through discovery, innovation, and collaboration.”

The Versiti Blood Research Institute is renowned for its advanced contributions to transfusion medicine and blood disorders. Dr. Di Paola’s leadership is expected to enhance the institute’s scientific strategy while fostering collaborative efforts across academic institutions and healthcare systems.

Versiti operates with a clear mission: to enhance patient health and support healthcare partners throughout the United States. By providing premier solutions in transfusion medicine and blood-related diseases, Versiti aims to improve patient outcomes and access to care.

In conclusion, the appointment of Dr. Jorge Di Paola as the Executive VP and Chief Scientific Officer represents an exciting new chapter for the Versiti Blood Research Institute. With his extensive background and deep commitment to advancing blood health, the institute is well-positioned to lead the way in innovative research and scientific collaboration.